home All News open_in_new Full Article

FDA approves expanded pediatric indications for YUFLYMA® (adalimumab

FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States  PR Newswire


today 7 d. ago attach_file Politics

attach_file Society
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Science
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics


ID: 712282030
Add Watch Country

arrow_drop_down